CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Is Acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF 3D Printing and Heart Failure: The Present and the Future A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. The Hospital Readmissions Reduction Program Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL Diuretic Therapy for Patients With Heart Failure JACC State-of-the-Art Review Angiotensin–neprilysin inhibition versus enalapril in heart failure

Clinical TrialFebruary 6, 2018, Volume 137, Issue 6

JOURNAL:Circulation Article Link

Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study

M .Kosiborod, CVD-REAL Investigators and Study Group. Keywords: SGLT2 inhibitor; death; diabetes mellitus; heart failure; observational studies

FULL TEXT PDF